**Chapter 12**

*Cells of the Immune System*

ClinicalTrials.gov identifier: NCT02947945. Available from: https://clinicaltrials.gov/ct2/show/

ClinicalTrials.gov identifier:

ct2/show/NCT03010436

NCT02947945

[43] U.S. National Library of Medicine. Reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) study. [Internet].

[44] U.S. National Library of Medicine. Benralizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) study. [Internet].

NCT03010436. [cited 2019 Aug 29]. Available from: https://clinicaltrials.gov/

**190**
